Trials / Unknown
UnknownNCT00753662
Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
Phase 2 (Feasibility) Study of Transcranial Magnetic Stimulation as Additional Therapy to Drug Treatment in Patients With Alzheimer's Disease
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this trial is to assess the ability of Transcranial Magnetic Stimulation with H2 coil to prefrontal and parieto-temporal cortex to improve cognitive performance in patients with Alzheimer's disease which received drug treatment. This study is a single-center, double-blind 4 months duration trial.
Detailed description
Primary outcome measure: ADAS-COG (time frame baseline, 2 months, 4 months) Secondary outcome measure: CGI-C, Neuropsychological computerized test (Mindstream), FAB,ADL, Beck Depression Inventory-time frame baseline,1 month (visit 12) 2 months (visit 16), 4 months (visit 17). Estimated enrollment: 45 patients Estimated Study start Date: November 2008 Estimated Study Completion date: November 2012 Number of arms: 3 Interventions details: H2 coil device for Transcranial Magnetic Stimulation with MAGSTIM to prefrontal and parieto-temporal regions bilaterally with frequency 10Hz in one arm, 1Hz in the second arm, and sham-stimulation with frequency 10Hz/1Hz in third arm. Ages: 50-80 Genders: both
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 1Hz TMS with H2 coil | 1Hz TMS with H2 coil to prefrontal and parieto-temporal cortex |
| DEVICE | 10Hz TMS with H2 coil to prefrontal and parieto-temporal cortex | 10Hz TMS with H2 coil to prefrontal and parieto-temporal cortex |
| DEVICE | SHAM TMS with H2 coil | SHAM TMS with H2 coil to prefrontal and parieto-temporal cortex |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2008-09-16
- Last updated
- 2011-09-13
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00753662. Inclusion in this directory is not an endorsement.